Edgestream Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,666	Closed	-$267K	–	879
2023 Q1	$267K	Buy	+6,666	New	+$267K	0.03%	488
2022 Q4	–	Sell	-17,111	Closed	-$709K	–	615
2022 Q3	$709K	Buy	+17,111	New	+$709K	0.05%	314